Results 151 to 160 of about 37,394 (238)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis. [PDF]

Front Immunol, 2022
Yan J, Zhao J, Ning X, Qin Y, Xing Y, Wang Y, Jia Q, Huang B, Ma R, Lei C, Zhou M, Yu Z, Zhang Y, Guo WF, Sun S.   +14 more
europepmc   +1 more source

Treatment of Immunoglobulin Light Chain Amyloidosis [PDF]

Mayo Clinic Proceedings, 2015
Angela Dispenzieri, Francis Buadi, Shaji K. Kumar, Craig B. Reeder, Tamur Sher, Martha Q. Lacy, Robert A. Kyle, Joseph R. Mikhael, Vivek Roy, Nelson Leung, Martha Grogan, Prashant Kapoor, John A. Lust, David Dingli, Ronald S. Go, Yi Lisa Hwa, Suzanne R. Hayman, Rafael Fonseca, Sikander Ailawadhi, P. Leif Bergsagel, Ascher Chanan-Khan, S. Vincent Rajkumar, Stephen J. Russell, Keith Stewart, Steven R. Zeldenrust, Morie A. Gertz   +25 more
openaire   +1 more source

Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs. [PDF]

, 2019
Deposits of amyloid fibrils of α-synuclein are the histological hallmarks of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, with hereditary mutations in α-synuclein linked to the first two of these conditions.
Boyer, David R, Eisenberg, David S, Fan, Weijia, Jiang, Lin, Li, Binsen, Sawaya, Michael R, Sun, Chuanqi   +6 more
core  

Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [PDF]

, 2017
Background. Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process. Methods.
Hopfer, Helmut, Mihatsch, Michael J., Wiech, Thorsten   +2 more
core  

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives

Journal of Blood Medicine, 2019
Shayna Sarosiek, Vaishali Sanchorawala Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USACorrespondence: Shayna Sarosiek; Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and ...
Sarosiek S, Sanchorawala V
doaj  

Amyloid cranial polyneuropathy: A rare neurological presentation of immunoglobulin light-chain amyloidosis. [PDF]

Aging Med (Milton), 2021
Agarwal A, Paul Wilson B, Kuruvilla Mathews P, Viggeswarpu S, Kango Gopal G.   +4 more
europepmc   +1 more source

T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy. [PDF]

Clin Transl Med, 2021
Wang Y, Xu L, Zhao W, Chen X, Wen L, Duan W, Yu XJ, De Zhou F, Liu Y, Hao J, Huang X, Lu J, Ge Q.   +12 more
europepmc   +1 more source

Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study. [PDF]

Sci Rep, 2022
Palmer C, Truong VT, Slivnick JA, Wolking S, Coleman P, Mazur W, Zareba KM.   +6 more
europepmc   +1 more source

Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients. [PDF]

Front Med (Lausanne)
Song L, Su Y, Li R, Du S, Xue Y, Gu Y, Chen J, Xing X, Shen Z, Wei Y.   +9 more
europepmc   +1 more source

Proving Bone Marrow Plasma Cell Clonality by Flow Cytometry: An Important Tool in the Diagnosis of Immunoglobulin Light-Chain Amyloidosis. [PDF]

Biomedicines
Badelita SN, Sandu HM, Coriu D, Jercan A, Barbu S, Zidaru L, Himcinschi ME, Dobrea C, Popescu M, Popa DC.   +9 more
europepmc   +1 more source